These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12608473)

  • 41. Predictive value of diminutive colonic adenoma trial: the PREDICT trial.
    Schoenfeld P; Shad J; Ormseth E; Coyle W; Cash B; Butler J; Schindler W; Kikendall WJ; Furlong C; Sobin LH; Hobbs CM; Cruess D; Rex D;
    Clin Gastroenterol Hepatol; 2003 May; 1(3):195-201. PubMed ID: 15017491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Screening for colorectal cancer and polyps].
    Krieger Y; Fraser D; Odes HS; Krugliak P; Fraser GM
    Harefuah; 1992 Mar; 122(6):354-6, 408. PubMed ID: 1582622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Colorectal cancer screening: is one-year surveillance sigmoidoscopy necessary?
    Brint SL; DiPalma JA; Herrera JL
    Am J Gastroenterol; 1993 Dec; 88(12):2019-21. PubMed ID: 8249966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colorectal cancer test use--Maryland, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biopsy of colorectal polyps is not adequate for grading of neoplasia.
    Gondal G; Grotmol T; Hofstad B; Bretthauer M; Eide TJ; Hoff G
    Endoscopy; 2005 Dec; 37(12):1193-7. PubMed ID: 16329016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Colorectal carcinoma: is screening possible?
    Bonelli L
    Tech Coloproctol; 2004 Dec; 8 Suppl 2():s267-72. PubMed ID: 15666104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of once-only flexible sigmoidoscopy screening on the outcomes of subsequent faecal occult blood test screening.
    Brown JP; Wooldrage K; Kralj-Hans I; Wright S; Cross AJ; Atkin WS
    J Med Screen; 2019 Mar; 26(1):11-18. PubMed ID: 30282520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Rectoscopy and Hemoccult-II as initial diagnosis. A procedure in patients with symptoms of irritable colon].
    Jensen BM; Holtved E; Kronborg O; Nørgård JR; Fenger C
    Ugeskr Laeger; 1994 Aug; 156(34):4795-7, 4800. PubMed ID: 7992411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test.
    Crotta S; Segnan N; Paganin S; Dagnes B; Rosset R; Senore C
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):633-8. PubMed ID: 22426085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of proximal and distal colorectal cancer following flexible sigmoidoscopy: a population-based cohort study.
    Rabeneck L; Lewis JD; Paszat LF; Saskin R; Stukel TA
    Am J Gastroenterol; 2008 Aug; 103(8):2075-82. PubMed ID: 18684198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The estimation of sensitivity and specificity in colorectal cancer screening methods.
    Walter SD; Frommer DJ; Cook RJ
    Cancer Detect Prev; 1991; 15(6):465-9. PubMed ID: 1782636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mass screening for colorectal cancer].
    Faivre J; Tazi MA; Launoy G
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S7-14. PubMed ID: 8935859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flexible sigmoidoscopy as a colorectal cancer screening test in the general population: recruitment phase results of a randomized controlled trial in Lombardia, Italy.
    Andreoni B; Crosta C; Lotti M; Carloni M; Marzona L; Biffi R; Luca F; Pozzi S; Cenciarelli S; Senore C
    Chir Ital; 2000; 52(3):257-62. PubMed ID: 10932370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening.
    Jouve JL; Remontet L; Dancourt V; Lejeune C; Benhamiche AM; Faivre J; Esteve J
    Br J Cancer; 2001 Jun; 84(11):1477-81. PubMed ID: 11384097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prevention of colorectal carcinoma. Annual hemoccult test and sigmoidoscopy every 5 years].
    Rosenbaum A; Riemann JF
    MMW Fortschr Med; 2000 Aug; 142(31-32):27-9. PubMed ID: 10992763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years' old population.
    Brevinge H; Lindholm E; Buntzen S; Kewenter J
    Int J Colorectal Dis; 1997; 12(5):291-5. PubMed ID: 9401844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complications of screening flexible sigmoidoscopy.
    Levin TR; Conell C; Shapiro JA; Chazan SG; Nadel MR; Selby JV
    Gastroenterology; 2002 Dec; 123(6):1786-92. PubMed ID: 12454834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial.
    Larsen IK; Grotmol T; Almendingen K; Hoff G
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):477-83. PubMed ID: 17363335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.